Day One, September 4, 2025Thursday, 4 September 2025 - MT (Mexican Pacific Time, GMT-07:00)

Begin the conference by looking forward, to try and predict what the market access and patient services functions will look like in the future. Working ahead of the downstream effect, benchmark with organizations on how to optimize market access infrastructure for future headwinds and challenges.

• Discuss the future of medication access and how hub programs are suspected to be utilized
• Hypothesize on the scope and implementation of new roles
• Ensure that your program design remains innovative throughout the coming years

Delve into the core elements that drive the successful implementation of patient support programs. This session will highlight the foundational strategies and practices that ensure programs are not only launched effectively but also deliver sustained value. Attendees will gain a clear understanding of the essential components that contribute to program success and how to apply them in their own initiatives. Attendees will gain actionable insights into these areas:

• Strategic Planning and Design: explore the importance of thorough planning and design, including setting clear objectives, understanding patient needs and aligning program goals with organizational priorities.
• Integration of Technology and Human Touch: learn how to balance digital tools with human interactions to create a seamless and supportive patient experience that enhances engagement and adherence.
• Continuous Evaluation and Adaptation: discover the significance of ongoing program evaluation and the use of data-driven insights to adapt and refine strategies for continuous improvement and optimal outcomes.

• Provide a comprehensive understanding of the existing regulatory landscape governing patient support services and hub models, including OIG guidelines, compliance standards and industry best practices

• Gain valuable insights into the latest enforcement actions and the ramifications of recent cases

• Uncover the top areas of focus for 2025 and 2026

As the IRA continues to unfold, take a fresh look at how organizations are navigating emerging challenges and patient service shifts while preparing for potential regulatory changes under the new administration. Run through the timeline to learn the effects that the IRA has had on the industry thus far as well as the implementations to come.

8 months into the new administration, use this session as an opportunity to level-set on the current state of the healthcare industry. As priorities and regulatory agendas are reassessed, uncover the top priorities for industry leaders looking to navigate the evolving market access landscape and better position their organization for long term success.

• Look at key healthcare policies and initiatives that are likely to take shape under the new administration
• Learn how the administration’s approach to pricing, IRA and affordability could impact manufacturers and other stakeholders
• Discover best practices to remain engaged and ahead of everchanging developments

In an era where organizations are inundated with data, effective management is critical to justifying investment and driving impactful patient services and commercial models. Explore best practices for structuring, sharing and optimizing data internally across teams while also ensuring actionable insights for stakeholders and increasing visibility to the patient journey.

• Ensure your organization has a solid data strategy foundation, with an effective data source and/or someone to manage it
• Define strategies to manage data internally, including the varying access levels for different teams, such as commercial, medical, analytics, vendors, etc.
• Learn best practices on how to interpret and segment data, balanced with fast delivery and quality assurance

While patient service programs are not designed to be profit-driven, there is an increased demand for programs to qualitatively and quantitatively show their story. Explore how to effectively use data to demonstrate program success and educate stakeholders on the key outcomes beyond traditional metrics.

• Learn best practices to define and measure your program’s return on objective, as opposed to return on investment
• Identify specific KPIs, and ways to hold your hub program accountable, to deliver on commercial objectives
• Understand how to use data to evaluate and evolve your hub program based on defined objectives

During this session, have an opportunity to level set and gain a deeper, macro-level understanding of how pricing, distribution, copay and all other aspects of your patient support program goes into the GTN calculation and has a downstream effect. Learn non-traditional ways to save money, balance GTN and create a sustainable patient hub.

The evolving market landscape, marked by tight budgets and the growing adoption of biosimilars, presents new challenges and opportunities for patient services. This session will explore how changing budgets, coupled with the commercial and reimbursement complexities of biosimilars, are reshaping strategies and partnerships.

• Discover how biosimilars are impacting the patient services industry/budget, and how this differs from a biologic
• Navigate the challenges surrounding a Q-code versus a J-code, understanding what makes biosimilar coding unique
• Learn how to define your business narrative through ASP (average sale price) management
• Align PSS strategy with evolving commercial objectives for biosimilars